Patient Guide: A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 45 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06099782
Status: ACTIVE_NOT_RECRUITING
Condition: Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Melanoma
Phase: PHASE2

Find a Study Location Near You

This study is available at 45 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Alexander City, Alabama
  • Anchorage, Alaska
  • Springdale, Arkansas
  • • And 42 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily